The original members of the Oregon State Elks’ visual committee, which helped start the Elks Children’s Eye Clinic are shown in this archive picture from 1950. Those pictured are Arnold N. Nicolai, Frank Hise, Hal Randall, Robert Mulvey and Marc Bowman. (OHSU)

Kweku Wilson will be receiving his Ph.D. in Health Systems and Policy from the OHSU-PSU School of Public Health. Wilson, a native of Ghana, came to Oregon in 2000 to begin master’s degree studies, eventually coming to Portland to earn another master’s at PSU and then pursuing his Ph.D. (OHSU)

Christine Lasich, R.N., M.S.N., A.G.A.C.N.P.-B.C., graduating from the OHSU School of Nursing, 2018. (OHSU)

Bo Weber, Pharm.D., graduating from the OSU/OHSU College of Pharmacy, 2018. (OHSU)

Eddie Ramirez, D.M.D., graduating from the School of Dentistry, 2018. (OHSU)

Joseph Quinn, M.D., professor of neurology in the OHSU School of Medicine and director of OHSU’s Parkinson Disease and Movement Disorders Program, (right) examines a patient with Parkinson's disease, June 14, 2018. (OHSU/Kristyna Wentz-Graff)

Joseph Quinn, M.D., professor of neurology in the OHSU School of Medicine and director of OHSU’s Parkinson Disease and Movement Disorders Program, (right) examines a patient with Parkinson's disease, June 14, 2018. (OHSU/Kristyna Wentz-Graff)

Joseph Quinn, M.D., professor of neurology in the OHSU School of Medicine and director of OHSU’s Parkinson Disease and Movement Disorders Program, (right) examines a patient with Parkinson's disease, June 14, 2018. (OHSU/Kristyna Wentz-Graff)

Leslie Muldoon, Ph.D. (left) talks with Edward Neuwelt, M.D., in the lab at OHSU. Neuwelt has spent more than 20 years researching pediatric hearing loss caused by platinum-based chemotherapies. A clinical trial based on his work has found a treatment protocol that reduces hearing loss by nearly 50 percent when treating a form of pediatric liver cancer. (OHSU/Kristyna Wentz-Graff)

Leslie Muldoon, Ph.D. (left) talks with Edward Neuwelt, M.D., in the lab at OHSU. Neuwelt has spent more than 20 years researching pediatric hearing loss caused by platinum-based chemotherapies. A clinical trial based on his work has found a treatment protocol that reduces hearing loss by nearly 50 percent when treating a form of pediatric liver cancer. (OHSU/Kristyna Wentz-Graff)